BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 23313086)

  • 1. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
    Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
    J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
    Falagas ME; Rafailidis PI; Kofteridis D; Virtzili S; Chelvatzoglou FC; Papaioannou V; Maraki S; Samonis G; Michalopoulos A
    J Antimicrob Chemother; 2007 Nov; 60(5):1124-30. PubMed ID: 17884829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
    Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
    Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
    Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
    J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study.
    Simkins J; Muggia V; Cohen HW; Minamoto GY
    Transpl Infect Dis; 2014 Oct; 16(5):775-82. PubMed ID: 25092500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
    Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
    BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
    Ben-David D; Kordevani R; Keller N; Tal I; Marzel A; Gal-Mor O; Maor Y; Rahav G
    Clin Microbiol Infect; 2012 Jan; 18(1):54-60. PubMed ID: 21722257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
    Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Wu D; Cai J; Liu J
    South Med J; 2011 Feb; 104(2):106-10. PubMed ID: 21258230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors.
    Amit S; Mishali H; Kotlovsky T; Schwaber MJ; Carmeli Y
    Clin Microbiol Infect; 2015 Jan; 21(1):30-4. PubMed ID: 25636924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.
    Hoxha A; Kärki T; Giambi C; Montano C; Sisto A; Bella A; D'Ancona F;
    J Hosp Infect; 2016 Jan; 92(1):61-6. PubMed ID: 26319590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae infections are associated with higher mortality compared to carbapenem-susceptible K. pneumoniae infections in the intensive care unit: a retrospective cohort study.
    Yao Y; Zha Z; Li L; Tan H; Pi J; You C; Liu B
    J Hosp Infect; 2024 Jun; 148():30-38. PubMed ID: 38513959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
    Bleumin D; Cohen MJ; Moranne O; Esnault VL; Benenson S; Paltiel O; Tzukert K; Mor-Yosef Levi I; Ben-Dov IZ; Levi R; Bloch A; Haviv YS
    J Infect; 2012 Oct; 65(4):318-25. PubMed ID: 22722020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
    Ny P; Nieberg P; Wong-Beringer A
    Am J Infect Control; 2015 Oct; 43(10):1076-80. PubMed ID: 26190386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis.
    Kohler PP; Volling C; Green K; Uleryk EM; Shah PS; McGeer A
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1319-1328. PubMed ID: 28950924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study of risk factors for carbapenem-resistant Klebsiella pneumoniae acquisition among ICU patients.
    Hu Y; Ping Y; Li L; Xu H; Yan X; Dai H
    J Infect Dev Ctries; 2016 Mar; 10(3):208-13. PubMed ID: 27031451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
    Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
    Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
    Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
    Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing.
    Zhang G; Zhang M; Sun F; Zhou J; Wang Y; Zhu D; Chen Z; Chen Q; Chang Q; Liu H; Chai W; Pan H
    J Infect Public Health; 2020 Nov; 13(11):1710-1714. PubMed ID: 33082112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.